Alfred G. Gilman

Alfred G. Gilman was a renowned American pharmacologist and Nobel laureate who made significant contributions to the field of pharmacology, particularly in the discovery of G proteins. Born in New Haven, Connecticut, Gilman developed an interest in science and medicine at an early age, inspired by his father, Alfred Gilman Sr., a pharmacologist at Yale University. Gilman's work on G protein-coupled receptors led to a deeper understanding of cell signaling pathways, involving Martin Rodbell, Eric Kandel, and Louis Ignarro. His research collaborations with University of Texas Southwestern Medical Center and National Institutes of Health colleagues, including Michael Brown and Joseph Goldstein, further advanced the field of molecular biology.

● Early Life and Education

Gilman's academic journey began at Yale University, where he earned his undergraduate degree in biology and chemistry. He then pursued his graduate studies at Case Western Reserve University, earning his Ph.D. in pharmacology under the guidance of Theodore Rall. During his time at Case Western Reserve University, Gilman was exposed to the works of prominent scientists, including Earl Sutherland, Fritz Lipmann, and Hans Krebs. His early research experiences at National Institutes of Health and University of Virginia laid the foundation for his future work on G proteins and cell signaling, involving Robert Lefkowitz, Brian Kobilka, and Roger Guillemin.

● Career

Gilman's academic career spanned several institutions, including University of Virginia and University of Texas Southwestern Medical Center, where he held various positions, including chairman of the pharmacology department. His research focused on the regulation of adenylate cyclase and the discovery of G proteins, which led to a greater understanding of signal transduction pathways, involving Edwin Krebs, Alfred Hershey, and Barbara McClintock. Gilman's work also explored the role of G proteins in disease, including cancer and neurological disorders, in collaboration with David Baltimore, Michael Bishop, and Harold Varmus. His contributions to the field of pharmacology have had a lasting impact on our understanding of cellular signaling and disease mechanisms, as recognized by the American Society for Pharmacology and Experimental Therapeutics and the National Academy of Sciences.

● Research and Discoveries

Gilman's research on G proteins led to the discovery of a new class of proteins that play a crucial role in cell signaling pathways, involving Sol Spiegelman, H. Robert Horvitz, and Randy Schekman. His work, in collaboration with Martin Rodbell, demonstrated that G proteins are involved in the regulation of adenylate cyclase and the production of cyclic AMP, a key second messenger in cell signaling, as recognized by the Lasker Award and the Wolf Prize in Medicine. Gilman's research also explored the role of G proteins in disease, including cancer and neurological disorders, such as Alzheimer's disease and Parkinson's disease, in collaboration with Stanley Prusiner, Eric Wieschaus, and Christiane Nüsslein-Volhard. His discoveries have had a significant impact on our understanding of cellular signaling and disease mechanisms, with implications for the development of new therapies and treatments, as recognized by the American Cancer Society and the Michael J. Fox Foundation.

● Awards and Honors

Gilman's contributions to the field of pharmacology were recognized with numerous awards and honors, including the Nobel Prize in Physiology or Medicine in 1994, which he shared with Martin Rodbell. He was also awarded the Lasker Award, the Wolf Prize in Medicine, and the Albert Lasker Award for Basic Medical Research, in recognition of his work on G proteins and cell signaling, as acknowledged by the National Institute of General Medical Sciences and the American Heart Association. Gilman was elected to the National Academy of Sciences and the Institute of Medicine, and he served as president of the American Society for Pharmacology and Experimental Therapeutics, alongside Elizabeth Blackburn, Carol Greider, and Jack Szostak.

● Personal Life

Gilman was born in New Haven, Connecticut, to Alfred Gilman Sr. and Mabel Gilman. He grew up in a family of scientists and academics, with his father being a prominent pharmacologist at Yale University. Gilman was married to Kathleen Gilman, and they had two children together, Amy Gilman and Edward Gilman. He passed away on December 23, 2015, at the age of 74, in Dallas, Texas, leaving behind a legacy of scientific contributions and a lasting impact on the field of pharmacology, as remembered by the University of Texas Southwestern Medical Center and the National Institutes of Health. Category:American pharmacologists